Active substance
Results for the substance ozanimod
2 results
About this active substance
Ozanimod is a sphingosine-1-phosphate receptor modulator used in the treatment of relapsing multiple sclerosis and moderate to severe ulcerative colitis. It works by reducing lymphocyte migration into the central nervous system or intestinal mucosa, thereby decreasing inflammation.
The medication is administered orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.
Patients should be aware of potential side effects, such as headache, infections, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms.
Common side effects include headache, infections, and elevated liver enzymes. In rare cases, severe reactions such as bradycardia or macular edema may occur. Patients should be informed of these risks before use.
The medication is administered orally, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.
Patients should be aware of potential side effects, such as headache, infections, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms.
Common side effects include headache, infections, and elevated liver enzymes. In rare cases, severe reactions such as bradycardia or macular edema may occur. Patients should be informed of these risks before use.